BIOMAT Database Logo BIOMAT Database Logo

TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway. 2018

Ying Xing, and Yuechao Liu, and Tianbo Liu, and Qingwei Meng, and Hailing Lu, and Wei Liu, and Jing Hu, and Chunhong Li, and Mengru Cao, and Shi Yan, and Jian Huang, and Ting Wang, and Li Cai
The Fourth Department of Medical Oncology, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150040, China.

The highly refractory nature of non-small cell lung cancer (NSCLC) to chemotherapeutic drugs is an important factor resulting in its poor prognosis. Recent studies have revealed that tumour necrosis factor alpha-induced protein 8 (TNFAIP8) is involved in various biological and pathological processes of cells, but their underlying mechanisms in processes ranging from cancer development to drug resistance have not been fully elucidated. TNFAIP8 expression in clinical NSCLC samples was examined through immunohistochemistry (IHC). After adjusting for patients' characteristics with propensity score matching, Kaplan-Meier analysis and Cox regression analysis were performed for comparison of patients' survival according to the TNFAIP8 level. Lentiviral transfection with TNFAIP8-specific shRNAs was used to establish stable TNFAIP8 knockdown (TNFAIP8 KD) NCI-H460, A549 and cis-diamminedichloroplatinum II resistant A549 (A549/cDDP) cell lines. Cell proliferation and viability were assessed by CCK-8 assay. Cell cycle was examined by flow cytometry. Multiple pathways regulated by TNFAIP8 KD were revealed by microarray analysis. We found that high TNFAIP8 expression was associated with advanced pT stage, advanced pTNM stage, lymph node metastasis and unfavourable survival in NSCLC patients. TNFAIP8 shRNAs reduced in vitro cancer cell proliferation and in vivo tumor growth. Additionally, TNFAIP8 KD increased the sensitivity of NSCLC cells to cisplatin in vitro and in vivo. Conversely, up-regulation of TNFAIP8 promoted the proliferation and drug resistance to cisplatin of NSCLC cells. TNFAIP8 influences cancer progression pathways involving the MDM2/p53 pathway. Indeed, we observed that TNFAIP8 KD mediated the MDM2 downregulation and the p53 ubiquitination, thereby decreasing the degradation of p53 protein. shRNA p53 reversed TNFAIP8 shRNA-mediated regulation of cell proliferation, cell cycle, cisplatin sensitivity, and expression levels of RAD51, a DNA repair gene. Our work uncovers a hitherto unappreciated role of TNFAIP8 in NSCLC proliferation and cisplatin chemoresistance that is mediated through the MDM2/p53 pathway. These findings might offer potential therapeutic targets for reversing cisplatin resistance in NSCLC patients with high TNFAIP8 expression.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Ying Xing, and Yuechao Liu, and Tianbo Liu, and Qingwei Meng, and Hailing Lu, and Wei Liu, and Jing Hu, and Chunhong Li, and Mengru Cao, and Shi Yan, and Jian Huang, and Ting Wang, and Li Cai
WDR79 promotes the proliferation of non-small cell lung cancer cells via USP7-mediated regulation of the Mdm2-p53 pathway.
April 2017, Cell death & disease,
Ying Xing, and Yuechao Liu, and Tianbo Liu, and Qingwei Meng, and Hailing Lu, and Wei Liu, and Jing Hu, and Chunhong Li, and Mengru Cao, and Shi Yan, and Jian Huang, and Ting Wang, and Li Cai
Knockdown of GINS2 inhibits proliferation and promotes apoptosis through the p53/GADD45A pathway in non-small-cell lung cancer.
April 2020, Bioscience reports,
Ying Xing, and Yuechao Liu, and Tianbo Liu, and Qingwei Meng, and Hailing Lu, and Wei Liu, and Jing Hu, and Chunhong Li, and Mengru Cao, and Shi Yan, and Jian Huang, and Ting Wang, and Li Cai
α-Hederin promotes ferroptosis and reverses cisplatin chemoresistance in non-small cell lung cancer.
January 2024, Aging,
Ying Xing, and Yuechao Liu, and Tianbo Liu, and Qingwei Meng, and Hailing Lu, and Wei Liu, and Jing Hu, and Chunhong Li, and Mengru Cao, and Shi Yan, and Jian Huang, and Ting Wang, and Li Cai
High Kpnβ1 expression promotes non-small cell lung cancer proliferation and chemoresistance via the PI3-kinase/AKT pathway.
April 2018, Tissue & cell,
Ying Xing, and Yuechao Liu, and Tianbo Liu, and Qingwei Meng, and Hailing Lu, and Wei Liu, and Jing Hu, and Chunhong Li, and Mengru Cao, and Shi Yan, and Jian Huang, and Ting Wang, and Li Cai
TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53.
January 2016, Drug design, development and therapy,
Ying Xing, and Yuechao Liu, and Tianbo Liu, and Qingwei Meng, and Hailing Lu, and Wei Liu, and Jing Hu, and Chunhong Li, and Mengru Cao, and Shi Yan, and Jian Huang, and Ting Wang, and Li Cai
TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression.
December 2020, Molecular therapy. Nucleic acids,
Ying Xing, and Yuechao Liu, and Tianbo Liu, and Qingwei Meng, and Hailing Lu, and Wei Liu, and Jing Hu, and Chunhong Li, and Mengru Cao, and Shi Yan, and Jian Huang, and Ting Wang, and Li Cai
HAX1 enhances the survival and metastasis of non-small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway.
November 2020, Thoracic cancer,
Ying Xing, and Yuechao Liu, and Tianbo Liu, and Qingwei Meng, and Hailing Lu, and Wei Liu, and Jing Hu, and Chunhong Li, and Mengru Cao, and Shi Yan, and Jian Huang, and Ting Wang, and Li Cai
Overexpression of hsa_circ_0002874 promotes resistance of non-small cell lung cancer to paclitaxel by modulating miR-1273f/MDM2/p53 pathway.
February 2021, Aging,
Ying Xing, and Yuechao Liu, and Tianbo Liu, and Qingwei Meng, and Hailing Lu, and Wei Liu, and Jing Hu, and Chunhong Li, and Mengru Cao, and Shi Yan, and Jian Huang, and Ting Wang, and Li Cai
PAQR4 promotes cell proliferation and metastasis through the CDK4-pRB-E2F1 pathway in non-small-cell lung cancer.
January 2019, OncoTargets and therapy,
Ying Xing, and Yuechao Liu, and Tianbo Liu, and Qingwei Meng, and Hailing Lu, and Wei Liu, and Jing Hu, and Chunhong Li, and Mengru Cao, and Shi Yan, and Jian Huang, and Ting Wang, and Li Cai
125I Seed Promotes Apoptosis in Non-small Lung Cancer Cells via the p38 MAPK-MDM2-p53 Signaling Pathway.
January 2021, Frontiers in oncology,
Copied contents to your clipboard!